NanoBlade offers the latest technological advancements in healthcare and is revolutionizing pathology evaluation and concurrently enhancing cancer research. NanoBlade focuses on the continuous improvement of the medical device industry through the introduction of revolutionary processes and products. Proprietary technologies offered by this high-tech organization include fresh tissue sectioning and collection devices, rapid intraoperative evaluation tools and advanced imaging technologies offering 3-D reconstruction with cellular resolution.

This subsidiary is a realized investment and was sold and divested on 10/01/07.

For the latest news release, click here.